Table of Content

1 Market Overview
1.1 Botanical and Plant-Derived Drugs Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Botanical and Plant-Derived Drugs Market Size & Forecast
1.4.1 Global Botanical and Plant-Derived Drugs Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Botanical and Plant-Derived Drugs Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Botanical and Plant-Derived Drugs Market Drivers
1.5.2 Botanical and Plant-Derived Drugs Market Restraints
1.5.3 Botanical and Plant-Derived Drugs Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Yunnan Baiyao
2.1.1 Business Overview
2.1.2 Yunnan Baiyao SWOT Analysis
2.1.3 Yunnan Baiyao Botanical and Plant-Derived Drugs Products and Service Offered
2.1.4 Yunnan Baiyao Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.2 Tongrentang
2.2.1 Business Overview
2.2.2 Tongrentang SWOT Analysis
2.2.3 Tongrentang Botanical and Plant-Derived Drugs Products and Service Offered
2.2.4 Tongrentang Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.3 Tasly
2.3.1 Business Overview
2.3.2 Tasly SWOT Analysis
2.3.3 Tasly Botanical and Plant-Derived Drugs Products and Service Offered
2.3.4 Tasly Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.4 Sanjiu
2.4.1 Business Overview
2.4.2 Sanjiu SWOT Analysis
2.4.3 Sanjiu Botanical and Plant-Derived Drugs Products and Service Offered
2.4.4 Sanjiu Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.5 Zhongxin
2.5.1 Business Overview
2.5.2 Zhongxin SWOT Analysis
2.5.3 Zhongxin Botanical and Plant-Derived Drugs Products and Service Offered
2.5.4 Zhongxin Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.6 Haiyao
2.6.1 Business Overview
2.6.2 Haiyao SWOT Analysis
2.6.3 Haiyao Botanical and Plant-Derived Drugs Products and Service Offered
2.6.4 Haiyao Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.7 Taiji
2.7.1 Business Overview
2.7.2 Taiji SWOT Analysis
2.7.3 Taiji Botanical and Plant-Derived Drugs Products and Service Offered
2.7.4 Taiji Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.8 Tsumura
2.8.1 Business Overview
2.8.2 Tsumura SWOT Analysis
2.8.3 Tsumura Botanical and Plant-Derived Drugs Products and Service Offered
2.8.4 Tsumura Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.9 Schwabe
2.9.1 Business Overview
2.9.2 Schwabe SWOT Analysis
2.9.3 Schwabe Botanical and Plant-Derived Drugs Products and Service Offered
2.9.4 Schwabe Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.10 Madaus
2.10.1 Business Overview
2.10.2 Madaus SWOT Analysis
2.10.3 Madaus Botanical and Plant-Derived Drugs Products and Service Offered
2.10.4 Madaus Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.11 Weleda
2.11.1 Business Overview
2.11.2 Weleda SWOT Analysis
2.11.3 Weleda Botanical and Plant-Derived Drugs Products and Service Offered
2.11.4 Weleda Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.12 Blackmores
2.12.1 Business Overview
2.12.2 Blackmores SWOT Analysis
2.12.3 Blackmores Botanical and Plant-Derived Drugs Products and Service Offered
2.12.4 Blackmores Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.13 Arkopharma
2.13.1 Business Overview
2.13.2 Arkopharma SWOT Analysis
2.13.3 Arkopharma Botanical and Plant-Derived Drugs Products and Service Offered
2.13.4 Arkopharma Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.14 Sido Muncul
2.14.1 Business Overview
2.14.2 Sido Muncul SWOT Analysis
2.14.3 Sido Muncul Botanical and Plant-Derived Drugs Products and Service Offered
2.14.4 Sido Muncul Botanical and Plant-Derived Drugs Revenue and Gross Margin
2.15 Arizona Natural
2.15.1 Business Overview
2.15.2 Arizona Natural SWOT Analysis
2.15.3 Arizona Natural Botanical and Plant-Derived Drugs Products and Service Offered
2.15.4 Arizona Natural Botanical and Plant-Derived Drugs Revenue and Gross Margin
3 Global Botanical and Plant-Derived Drugs Market Competition, by Manufacturer
3.1 Global Botanical and Plant-Derived Drugs Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Botanical and Plant-Derived Drugs Players Market Share in 2023
3.2.2 Top 6 Botanical and Plant-Derived Drugs Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Botanical and Plant-Derived Drugs Players Head Office, Business Provided
3.4 Botanical and Plant-Derived Drugs Mergers & Acquisitions
3.5 Botanical and Plant-Derived Drugs New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Botanical and Plant-Derived Drugs Revenue in Value by Type (2019-2030)
4.2 Global Botanical and Plant-Derived Drugs Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Botanical and Plant-Derived Drugs Revenue by Application (2019-2030)
5.2 Global Botanical and Plant-Derived Drugs Revenue Share by Application (2019-2030)
6 Global Botanical and Plant-Derived Drugs Market Analysis by Regions
6.1 Global Botanical and Plant-Derived Drugs Revenue and Market Share by Regions
6.1.1 Global Botanical and Plant-Derived Drugs Revenue by Regions (2019-2030)
6.1.2 Global Botanical and Plant-Derived Drugs Revenue Market Share by Regions (2019-2030)
6.2 North America Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
6.3 Europe Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
6.4 Asia Pacific Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
6.5 South America Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
6.6 Middle East and Africa Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
7 North America Botanical and Plant-Derived Drugs by Country, by Type, and by Application
7.1 North America Botanical and Plant-Derived Drugs Revenue by Type (2019-2030)
7.2 North America Botanical and Plant-Derived Drugs Revenue by Application (2019-2030)
7.3 North America Botanical and Plant-Derived Drugs Revenue and Market Share by Countries
7.3.1 North America Botanical and Plant-Derived Drugs Revenue in Value by Country (2019-2030)
7.3.2 United States Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
7.3.3 Canada Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
7.3.4 Mexico Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Botanical and Plant-Derived Drugs by Country, by Type, and by Application
8.1 Europe Botanical and Plant-Derived Drugs Revenue by Type (2019-2030)
8.2 Europe Botanical and Plant-Derived Drugs Revenue by Application (2019-2030)
8.3 Europe Botanical and Plant-Derived Drugs Revenue and Market Share by Countries
8.3.1 Europe Botanical and Plant-Derived Drugs Revenue in Value by Country (2019-2030)
8.3.2 Germany Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
8.3.3 France Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
8.3.4 United Kingdom Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
8.3.5 Russia Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
8.3.6 Italy Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
8.3.7 Nordic Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Botanical and Plant-Derived Drugs by Country, by Type, and by Application
9.1 Asia Pacific Botanical and Plant-Derived Drugs Revenue by Type (2019-2030)
9.2 Asia Pacific Botanical and Plant-Derived Drugs Revenue by Application (2019-2030)
9.3 Asia Pacific Botanical and Plant-Derived Drugs Revenue and Market Share by Countries
9.3.1 Asia Pacific Botanical and Plant-Derived Drugs Revenue in Value by Country (2019-2030)
9.3.2 China Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
9.3.3 Japan Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
9.3.4 Korea Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
9.3.5 India Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
9.3.7 Australia Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Botanical and Plant-Derived Drugs by Country, by Type, and by Application
10.1 South America Botanical and Plant-Derived Drugs Revenue by Type (2019-2030)
10.2 South America Botanical and Plant-Derived Drugs Revenue by Application (2019-2030)
10.3 South America Botanical and Plant-Derived Drugs Revenue and Market Share by Countries
10.3.1 South America Botanical and Plant-Derived Drugs Revenue in Value by Country (2019-2030)
10.3.2 Brazil Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
10.3.3 Argentina Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Botanical and Plant-Derived Drugs by Country, by Type, and by Application
11.1 Middle East & Africa Botanical and Plant-Derived Drugs Revenue by Type (2019-2030)
11.2 Middle East & Africa Botanical and Plant-Derived Drugs Revenue by Application (2019-2030)
11.3 Middle East & Africa Botanical and Plant-Derived Drugs Revenue and Market Share by Countries
11.3.1 Middle East & Africa Botanical and Plant-Derived Drugs Revenue in Value by Country (2019-2030)
11.3.2 Turkey Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
11.3.3 Egypt Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
11.3.5 UAE Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
11.3.6 South Africa Botanical and Plant-Derived Drugs Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Botanical and Plant-Derived Drugs Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Botanical and Plant-Derived Drugs Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer